Modulating Immune Cell Activity Using Cylokine-induced Src Homology 2 And/Or High Temperature Requirement A-1 Read more about Modulating Immune Cell Activity Using Cylokine-induced Src Homology 2 And/Or High Temperature Requirement A-1 US Application 61/420,825Filed on 2010-12-08
Device And Method For Ensuring The Accuracy Of A Tracking Device In A Volume Read more about Device And Method For Ensuring The Accuracy Of A Tracking Device In A Volume US Application 60/626,947Filed on 2004-11-12
Use Of Cucurbitacins And Withanolides To Sensitize Cancer Cells To The Cytotoxic Effects Of Apo2L/TRAIL Read more about Use Of Cucurbitacins And Withanolides To Sensitize Cancer Cells To The Cytotoxic Effects Of Apo2L/TRAIL US Application 61/287,139Filed on 2009-12-16
Development Of Novel Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain:Part 2 Read more about Development Of Novel Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain:Part 2 US Application 61/300,349Filed on 2010-02-01
Novel Nitroxyl (HNO) Prodrugs And Biomedical Applications Thereof Read more about Novel Nitroxyl (HNO) Prodrugs And Biomedical Applications Thereof US Application 61/315,604Filed on 2010-03-19
Development Of A Vaccine Composed Of CpG Oligonucleolides Conjugated To Apoptotic Tumor Cells To Treat Cancer. Read more about Development Of A Vaccine Composed Of CpG Oligonucleolides Conjugated To Apoptotic Tumor Cells To Treat Cancer. US Application 61/309,802Filed on 2010-03-02
Diagnosis and Treatment of Cancer Through NUAK2 Assessment and Modulation Read more about Diagnosis and Treatment of Cancer Through NUAK2 Assessment and Modulation US Application 61/321,136Filed on 2010-04-05
Nitric Oxide-based Cancer Therapeutic Agents For Lung Cancers With Elevated Levels Of Reactive Oxygen Species (ROS) And/or Low Levels Of Antioxidant Defense/DNA Repair mechanisms. Read more about Nitric Oxide-based Cancer Therapeutic Agents For Lung Cancers With Elevated Levels Of Reactive Oxygen Species (ROS) And/or Low Levels Of Antioxidant Defense/DNA Repair mechanisms. US Application 61/261,175Filed on 2009-11-13
Programmed Death Ligand-1 (PD-L1) Immune Modulation Gene Therapy Read more about Programmed Death Ligand-1 (PD-L1) Immune Modulation Gene Therapy US Application 61/261,081Filed on 2009-11-13
Methods, Compositions And Kits For MiRNA In Situ Hybridization Detection, Quantification And Identification Of Cancer Biomarkers And Companion Diagnostic Assay For Cancer Therapy Read more about Methods, Compositions And Kits For MiRNA In Situ Hybridization Detection, Quantification And Identification Of Cancer Biomarkers And Companion Diagnostic Assay For Cancer Therapy US Application 61/253,617Filed on 2009-10-21